SEC Form D · filed March 1, 2017
XTL BIOPHARMACEUTICALS LTD
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
David H. Bassa · Raanana, L3DirectorDavid H. Kestenbaum · Raanana, L3ExecOded H. Nagar · Raanana, L3DirectorOssi H. Fain · Raanana, L3DirectorDobroslav H. Melamed · Raanana, L3DirectorJonathan H. Schapiro · Raanana, L3DirectorShlomo Shalev · Raanana, L3DirectorJoshua H. Levine · Raanana, L3ExecDoron H. Turgeman · Raanana, L3DirectorLaurence W. Cohen · NEW YORK, NYDirectorMatthew Gilmartin · NEW YORK, NYDirectorMichael J. Linn · NEW YORK, NYDirectorM. R. Lee · NEW YORK, NYExecGeorge B. Davis · New York, NYDirectorDon J. Seymour · George Town, Grand Cayman, Cayman IslandsDirectorDavid J. Bree · George Town, Grand Cayman, Cayman IslandsDirectorKevin R. Barcelona · NEW YORK, NYExecMatt L. Turck · New York, NYDirectorTyler Piercy · Miami, FLDirectorRafael C. Benavente · Miami, FLDirectorGeorge C. Zaczac · Miami, FLDirectorDonal R. Buckley · Co. Cork, IrelandDirectorThomas R. Spangler · Princess Anne, MDDirectorBryan R. Train · Richmond, United KingdomDirectorJason R. Levine · Princess Anne, MDExecDavid D. Rothschild · New York, NYDirectorMichael R. Silverman · Dallas, TXExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗